BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jnci/djv315
PubMed Identifier: 26586665
Publication URI: http://europepmc.org/abstract/MED/26586665
Type: Journal Article/Review
Volume: 108
Parent Publication: Journal of the National Cancer Institute
Issue: 2
ISSN: 0027-8874